Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent. Kim H, Kim JY, Choi HB, Lee JS, et al. J Med Virol 2025;97:e70584.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim H, Kim JY, Choi HB, Lee JS, et al. Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent. J Med Virol 2025;97:e70584.
PMID: 40905103